StonvexLoading…
StonvexStonvexStonvexCore line items from PRKS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.66B | $1.73B | $1.73B | $1.73B |
Operating Income | $365.44M | $463.29M | $459.75M | $507.53M |
Net Income | $168.35M | $227.50M | $234.20M | $291.19M |
EPS (Diluted) | $3.06 | $3.79 | $3.63 | $4.14 |
Total Assets | $2.62B | $2.57B | $2.63B | $2.33B |
Total Liabilities | $3.05B | $3.04B | $2.83B | $2.76B |
Cash & Equivalents | $99.76M | $115.89M | $246.92M | $79.20M |
Free Cash Flow OCF − CapEx | $162.60M | $231.71M | $200.08M | $363.88M |
Shares Outstanding | 54.99M | 60.01M | 64.49M | 70.28M |